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Periodontitis has been implicated as a risk factor for metabolic disorders such as type 2 diabetes,
atherosclerotic vascular diseases, and non-alcoholic fatty liver disease. Although bacteremias from dental
plaque and/or elevated circulating inflammatory cytokines emanating from the inflamed gingiva are
suspected mechanisms linking periodontitis and these diseases, direct evidence is lacking. We hypothesize
that disturbances of the gut microbiota by swallowed bacteria induce a metabolic endotoxemia leading
metabolic disorders. To investigate this hypothesis, changes in the gut microbiota, insulin and glucose
intolerance, and levels of tissue inflammation were analysed in mice after oral administration of
Porphyromonas gingivalis, a representative periodontopathogens. Pyrosequencing revealed that the
population belonging to Bacteroidales was significantly elevated in P. gingivalis-administered mice which
coincided with increases in insulin resistance and systemic inflammation. In P. gingivalis-administered
mice blood endotoxin levels tended to be higher, whereas gene expression of tight junction proteins in the
ileum was significantly decreased. These results provide a new paradigm for the interrelationship between
periodontitis and systemic diseases.
P
eriodontal diseases are mainly chronic infectious diseases result from response to a complex dental plaque
microbiome containing various periodontopathic bacteria species. Periodontal diseases destroys the tooth-
supporting tissues and leads to tooth loss if not adequately treated. Advanced form of the diseases affects
,10% to 15% of adults worldwide1.
Epidemiological evidence suggests that periodontal infection is associated with an increased risk of a variety of
diseases such as atherosclerotic vascular diseases2,3, type 2 diabetes4,5, and non-alcoholic fatty liver disease6.
Among the various periodontopathic bacteria, considerable research has focused on the role of Porphyromonas
gingivalis in possible mechanisms linking periodontal diseases and other human diseases, due to its unique
pathogenicity7 and its association with these various diseases.
Once an inflammatory lesion in the periodontium is established, bacteria from the dental plaque can invade
into the gingival tissue through the ulcerated sulcular epithelial lining of periodontal pockets and then dissem-
inate into the systemic circulation8. In addition, various proinflammatory cytokines are produced in the inflamed
periodontal tissue9 which can also enter the systemic circulation. Although the precise mechanisms have not been
clarified, the resulting bacteremia and increase in circulating inflammatory mediators may potentiate an inflam-
matory reaction in other tissues or organs. In fact, a number of studies have demonstrated elevated levels of serum
hs-CRP10 and IL-611,12 in periodontitis patients when compared with periodontally healthy subjects. By contrast,
there is little evidence for an increased detection and/or numbers of oral bacteria in the blood of periodontitis
patients when compared with periodontally healthy subjects13. In addition, we have shown that repeated oral
inoculation of P. gingivalis induced elevation of serum inflammatory markers (serum amyloid A and IL-6) in
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mice. However, no P. gingivaliswas detected in the blood at any time
point of these experiments14. Moreover, in this mouse model, a lim-
ited inflammatory cell infiltrate was seen in the gingival tissue.
It is well-known that obesity, a chronic disease characterized by an
excessive growth of adipose tissue, increases the risk of insulin res-
istance, diabetes, atherosclerosis, hypertension, chronic kidney dis-
ease, and cardiovascular morbidity and mortality15–17. Interestingly,
many of these diseases are also associated with inflammatory peri-
odontal diseases. Insulin resistance, a key feature of obesity, is a state
in which the sensitivity of target cells to respond to ordinary levels of
insulin is reduced. This insulin sensitivity is modulated in part by
adipokines. In obesity, adipokine production is either up-regulated
or down-regulated. Specifically, insulin resistance-associated adipo-
kines are usually up-regulated whereas insulin-sensitivity-associated
adipokines are down-regulated18.
Obesity is reported to be associated with periodontal diseases.
Saito et al. first reported that obese Japanese subjects weremore likely
to have periodontal disease than thin subjects19. Although later studies
supported the positive association between obesity and periodontitis20–22,
there are also studies showing no association between these two con-
ditions23.While there are several epidemiological studies demonstrat-
ing this association, there are few reports on the mechanism linking
obesity and periodontal diseases. One proposed mechanism involves
the adipocyte hypertrophy found in obesity. This adipocyte hyper-
trophy leads to infiltration of macrophages and other inflammatory
cells. This phenomenon results in low-grade chronic inflammation
and enhanced proinflammatory cytokine production24,25. Among the
many adipokines, TNF-a is considered a key player in inflammatory
cell activation and recruitment26. TNF-a produced by the adipocytes
together with TNF-a produced in the periodontal tissue may induce
further periodontal tissue destruction. However, several reports have
shown that serumTNF-a levels of periodontitis patients are either not
elevated or lower in periodontitis patients compared with non-peri-
odontitis subjects27. Thus, the pathogenic mechanisms for the effects
of periodontal disease affecting systemic disease and the specific
effects of the infection with periodontopathic bacteria on the patho-
logy of various tissues remain to be elucidated.
In this study, we propose that endotoxemia is responsible for
inflammation of various organs and tissues in this mouse model
through P. gingivalis oral administration. However, this endotoxe-
mia may not be induced directly by bacteria from the oral cavity, but
rather through changes in gut microbiota induced by inoculation of
bacteria from the oral cavity into the gut through swallowing.
Subsequent activation of proinflammatory genes within blood ves-
sels, adipose tissue and liver could increase the risk of atherosclerosis,
insulin resistance and non-alcoholic fatty liver disease (NAFLD),
respectively.
Results
Local and systemic inflammation in P. gingivalis-administered
mice. Our previous study and others demonstrated that repeated
oral gavage administration of P. gingivalis induced alveolar bone
resorption. However, whether this could be due to local inflamma-
tion of gingival tissue is still unresolved. Although serum IL-6 levels
significantly increased in P. gingivalis-administered mice compared
with sham-administeredmice, no difference of gingival inflammation,
which was minimal, between P. gingivalis-administered and sham-
administered mice was observed (Fig. 1).
P. gingivalis administration induces insulin resistance, liver steatosis,
andmacrophage infiltration in adipose tissue.To explore the effects
of oral gavage administration of P. gingivalis on insulin resistance,
we performed glucose and insulin tolerance tests. As shown in Fig. 2,
both glucose tolerance and insulin sensitivity was diminished in P.
gingivalis-administered mice compared with sham-administered
mice, despite similar body weight changes during the experimental
period (Supplementary Fig. S1). Although the effect of P. gingivalis
administration was relatively weak, a significant difference was ob-
served at 15 min for the insulin tolerance test, and anoverall effectwas
evident as shown in Figs. 2b and 2d. However, there were no differ-
ences in blood insulin levels between P. gingivalis-administered mice
and sham-administered mice (Supplementary Fig. S2). Oral gavage
administration of P. gingivalis promotedmacrophage infiltration into
the adipose tissue and a typical crown-like structurewas observed his-
tologically (Fig. 3a). Histological analysis showed that P. gingivalis-
administeredmice had accumulatedmuch higher amounts of hepatic
fat (Fig. 3b) and triglyceride (Fig. 3c), as compared to the sham-
administered mice.
P. gingivalis administration induces an inflammatory response in
adipose tissue. Next we compared gene expression profiles of
epididymal adipose tissue between P. gingivalis-administered and
sham-administered mice (Fig. 4). In P. gingivalis-administered
mice, expression of proinflammatory genes Tnfa, Ccl2, Il6, and
Il1b were significantly upregulated, whereas the genes that
improve insulin sensitivity Pparc, Ppara, C1qtnf9, Irs1, Sirt1, and
Slc2a4 were downregulated. In addition to proinflammatory genes,
expression of Angptl4 which is involved in insulin resistance was also
upregulated. These results suggest that oral gavage administration of
P. gingivalis induces an inflammatory response and insulin resistance
in adipose tissue. There was no difference in the expression of three
regulators of insulin signalling, Grn, Retn, and Lep, between P.
gingivalis-administered mice and sham-administered mice.
P. gingivalis administration induces an inflammatory response in
the liver and an inflammation-related gene response. Oral
administration of P. gingivalis led to increased mRNA expression
of the proinflammatory cytokines TNF-a and IL-6, as well as of
Fitm2 and Plin2, both of which are strongly associated with lipid
droplet formation in the liver. Furthermore, Acaca and G6pc,
which positively regulate fatty acid synthesis and gluconeogenesis
respectively, were also upregulated. On the other hand, mRNA
expression of the molecules having potentially anti-inflammatory
properties Pparc and Sirt1, were downregulated. In addition, expres-
sion of the insulin signalling gene Irs1 was also decreased compared
with sham-administered mice. We observed that not only gene
expression (Fig. 5a) but also protein levels of TNF-a were increased
in the liver of P. gingivalis-administered mice (Fig. 5b).
Oral administrationofP. gingivalis alters the gutmicrobial ecology.
After 10 cycles of oral administration of live P. gingivalis W83, the
contents of the distal 3cm of the small intestine (ileum) were
recovered immediately after euthanization by manual extrusion. We
defined the extent to which oral administration of P. gingivalis altered
the composition of the microbiota by pyrosequencing the 16S
ribosomal RNA genes in the ileum contents. In total, 41,557 (mean
6,926 reads/sample) and32,108 (mean5,351 reads/sample) sequencing
reads for the P. gingivalis-administered samples and the sham-
administered samples, respectively, were obtained by two sequenc-
ing runs. The majority of aligned reads were determined to be from
the phyla Firmicutes and Bacteroidetes, representing 55.4% and
38.7% of the flora respectively in P. gingivalis-administered mice,
and 72.8% and 17.0%, respectively in sham-administered mice. The
difference of the proportion of Bacteroidetes and Firmicutes between
P. gingivalis-administered mice and sham-administered mice was
statistically significant (Fig. 6a).
Notably, operational taxonomy unit (OTU)-based bacterial
diversity analysis revealed that the population belonging to
Bacteroidales was significantly elevated in P. gingivalis-administered
mice compared with sham-administered mice (Fig. 6b and 6c).
Because P. gingivalis belongs to the order Bacteroidales, increased
proportions of the order Bacteroidales could be due to the adminis-
tered P. gingivalis. To clarify this possible mechanism, DNA samples
www.nature.com/scientificreports
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of the ileum contents were amplified using P. gingivalis-specific pri-
mers. However, no P. gingivalis-specific DNA was detected (Sup-
plementary Fig. S3).
P. gingivalis administration increases serum endotoxin level.As it
has been reported that changes in the gut microbiota influence
metabolic endotoxemia, we compared the serum endotoxin levels
between P. gingivalis-administered mice and sham-administered
mice. As shown in Fig. 7a, endotoxin levels were very low after
overnight fasting, with no difference between P. gingivalis-admin-
istered mice and sham-administered mice. However, the endotoxin
levels dramatically increased if the mice were fed ad libitum
irrespective of P. gingivalis administration. The endotoxin level
tended to be higher in P. gingivalis-administered mice compared to
sham-administeredmice. However, this differencewas not statistically
significant (Fig. 7a). In order to further examine the effect of oral
administration of P. gingivalis on endotoxemia, the serum endotoxin
levels weremonitored at 1, 3, 12 hrs. after a single administration of P.
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Figure 1 | Systemic and local inflammation in P. gingivalis-administered and sham-administered mice (N5 8 in each group). (a) Serum level of IL-6.
All data aremeans6 SD. Significant differences were observed between the P. gingivalis-administered groups and the sham-administered group (***p,
0.001, Mann-Whitney U-test). (b) Histological findings of gingival tissues of P. gingivalis-administered and sham-administered mice. Sections of the
periodontium around the disto-buccal root of the first molar were H-E stained. Right panels are magnified views of the boxed areas. No difference of
gingival inflammation was observed between P. gingivalis-administered and sham-administered mice.
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Figure 2 | P. gingivalis induced insulin resistance. (a) Intraperitoneal glucose tolerance test. Blood glucose levels were determined at the indicated times
after intraperitoneal load of glucose (1 g/kg). (b) Area under blood concentration curve (AUC) of the Fig. 2a. (c) Intraperitoneal insulin tolerance test
(ITT). Blood glucose levels were determined at the indicated times after intraperitoneal load of insulin (0.5 unit/kg). (N 5 6 in each group). (d) Insulin
sensitivity was assessed by inverse AUC of ITT. All data are means 6 SD. (*p , 0.05; **p , 0.01, Mann-Whitney U-test).
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gingivalis. Serum endotoxin levels increased as early as 1 hr. after
administration, peaked at 3 hrs., and maintained these higher levels
until 12 hrs. (Fig. 7b). One hour after oral administration, P. gingivalis
was detected in the jejunum and ileum, and its proportion in the
microbial flora decreased at 3 hrs. Although P. gingivalis DNA was
detected in the colon at 16 hrs, the proportionofP. gingivalisDNAwas
extremely low because of far larger quantities of other bacteria in the
colon (Supplementary Fig. S4). At these time points, no P. gingivalis
was detected in the blood samples of P. gingivalis-adminstered mice
whereas other bacterial DNA was detected (Supplementary Fig. S5).
Changes in gene expression profiles in the intestine by oral ad-
ministration of P. gingivalis. Next we examined the effect of P.
gingivalis administration on the expression of genes that play impor-
tant role for prevention of metabolic syndrome and metabolic
endotoxemia in the small intestine (Fig. 8a) and inflammatory
responses in the large intestine (Fig. 8b). The expression of genes
that code intestinal alkaline phosphatase (Akp3) and tight junction
protein (Tjp1) in the small intestine were both downregulated in P.
gingivalis-administered mice compared to sham-administered mice.
In the samples of large intestine, mRNA expression of the proin-
flammatory cytokines IL-6, IL-12b, IFN-c and IL-17c were signifi-
cantly upregulated in P. gingivalis-administered mice compared to
sham-administered mice. However, there was no difference in
expression of IL-10 and TNF-a.
Discussion
Periodontal disease is a chronic inflammatory disease where groups
of periodontopathic bacteria such asP. gingivalis plays amajor role in
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Figure 3 | Relationship between P. gingivalis administration and inflammatory changes of epididymal adipose tissue and liver. (a) Epididymal adipose
tissues were fixed 10% formalin, sectioned, and stained with a rat anti-mouse F4/80 primary antibody (Abd Serotec). Arrow heads indicate F4/80
positive macrophages. (b) Oil red O staining of the liver tissue are shown. Increased number of lipid containing hepatocytes (arrow heads) are seen in
P. gingivalis-administered mice. (c) P. gingivalis administration increased hepatic triglyceride content. (N 5 8 in each group). All data are means 6 SD.
(**p , 0.01, Mann-Whitney U-test).
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Figure 4 | Effect of oral administration of P. gingivalis on the gene and protein expressions in epididymal adipose tissue. (a) Comparison of relative
gene expression levels in the adipose tissue between the P. gingivalis-administered and the sham-administered mice (N 5 8 in each group). The
relative quantity of experimental mRNA was normalized to the relative quantity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA.
(b) CTRP9 contents in the epididymal adipose tissue were determined by ELISA of tissue lysates. All data are means 6 SD. (*p , 0.05; **p , 0.01;
***p , 0.001, Mann-Whitney U-test).
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its initiation and progression. A number of epidemiological studies
have suggested that periodontal disease is a risk factor for various
systemic diseases and conditions, including cardiovascular disease,
type 2 diabetes, NAFLD, and rheumatoid arthritis28. Interestingly,
obesity increases the risk of these diseases29–31. In addition, obesity is
also associated with an increased risk of periodontal disease.
Therefore, it is possible that periodontal disease and obesity have
similar effects on these systemic conditions.
The common systemic effect of obesity and periodontal disease is
considered to be low-grade inflammation13. It is well-known that
diet-induced obesity is implicated in systemic low grade inflam-
mation. Nutritional fatty acids activate Toll-like receptor 4 (TLR4)
signalling in adipocytes and macrophages. In addition, the capacity
of fatty acids to induce inflammatory signalling in adipocytes or
macrophages is blunted in the absence of TLR432,33. Furthermore,
adipose tissue lipolysis from hypertrophied adipocytes, could serve
as a naturally occurring ligand for TLR4 to induce inflammation. It is
apparent that gut microbial ecology could be an important factor in
the development of obesity by affecting energy homeostasis. For
example, Cani et al. elegantly demonstrated that the composition
of the gut microbiota is influenced by a high-fat diet- and genetically
obese ob/ob-induced metabolic endotoxemia34. Components origin-
ating from the gut microbiota, such as lipopolysaccharide, lipotei-
choic acid, peptidoglycan, flagellin, and bacterial DNA can cause
immune system activation and subsequent inflammation.
Proposed mechanisms for periodontal diseases inducing systemic
inflammation have included: (i) the direct effect of infectious agents
or their products, and (ii) increased expression of cytokines, chemo-
kines, and cell adhesionmolecules produced in periodontitis lesions35.
Additional mechanisms may include, (iii) translocation of swallowed
P. gingivalis from the gut to the circulationg system, and (iv) alteration
of gut microbial composition-induced increases in gut epithelial per-
meability by swallowed P. gingivalis. The first hypothesis is based on
the lesion size of periodontal disease (periodontitis). It is reported that
the mean dentogingival epithelial surface area of periodontitis
patients where subgingival biofilm is contacting a thinning and/or
ulcerated gingival sulcular epithelium is approximately 20 cm2 36.
This area is considered to act as an entrance of periodontopathic
bacteria into the systemic circulation. This mechanism is supported
by a numberof studies that have demonstrated an associationbetween
periodontal disease and endotoxemia. However, periodontal treat-
ment-induced endotoxemia is detectable as early as 5 min after
instrumentation and disappears at 30 min37,38. In our study, increases
in the serum endotoxin level was observed 1 hr after a single
administration of P. gingivalis and peaked at 3 hrs. For the second
hypothesis, there is no direct evidence that increased inflammatory
markers in periodontitis patients are in fact derived from inflamed
periodontal tissues. For the third possibility, althoughP. gingivaliswas
detected in the jejunal and ileal contents, and colonic contents up to
3 hrs and 16 hrs after a single administration, respectively, it was not
detected in the blood of P. ginigivalis-administered mice whereas
other bacterial DNA was detected in the blood. Therefore, it is highly
likely that detected endotoxins are not derived from P. gingivalis.
Given that recent findings have implicated an altered gut micro-
biota as a contributor of not only metabolic diseases such as athero-
sclerosis39,40, type 2 diabetes41, and NAFLD42 but also immune
diseases such as rheumatoid arthritis43 that are also associated with
periodontitis, it is reasonable to assume that the systemic inflammat-
ory changes seen in P. gingivalis-administered mice could be attrib-
utable to this altered gut microbiota. Furthermore, periodontal
diseases themselves could be modulated by alteration of gut micro-
biota-induced systemic inflammation. In support of this hypothesis,
it has been reported that high-fat diet-induced obesity increased
alveolar bone resorption, a characteristic feature of periodontitis44,45.
The swallowed saliva of periodontitis patients is reported to con-
tain up to 109 bacteria/ml, in 1.0–1.5 L/day46–48, making a total of
greater than 1012 bacteria/day. Since the bacterial flora of the oral
cavity is distinct from that of the gut49, it is possible that swallowed
bacteria could affect the composition of the gut microflora. In fact, it
has been reported that oral probiotic intervention alters gut bacterial
composition50. Thus, it is unlikely that oral bacteria alone could be
causative agents of endotoxemia in periodontitis patients.
In the present study, oral administration of P. gingivalis induced a
change of bacterial composition in the ileal microflora. Although
several studies have shown the beneficial effect of Bacteroidetes phy-
lum on the gut51,52, we observed an increased proportion of the order
Bacteroidales belonging Bacteroidetes phylum, accompanied by
insulin resistance and the alteration of gene expression in adipose
tissue and liver. The expression of several proinflammatory genes
and anti-inflammatory or insulin sensitivity-improving genes were
upregulated or downregulated, respectively, in the adipose tissue and
the liver ofP. gingivalis-administeredmice. In addition, expression of
Sirt1 which is reported to induce an increase in glucose uptake and
insulin signalling was also downregulated. It has also been reported
that SIRT1 expression is inversely related to inflammatory gene
expression, particularly TNF-a. These changes in proinflammatory
and anti-inflammatory gene expression may contribute to increases
in serum glucose levels and in insulin intolerance. Although the effect
of P. gingivalis is not robust, continuous deterioration of glucose
metabolism could have significant effect.
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Figure 5 | Effect of oral administration of P. gingivalis on the gene and protein expressions in liver. (a) Comparison of relative gene expression levels in
the liver tissue between the P. gingivalis-administered and the sham-administered mice (N 5 8 in each group). The relative quantity of experimental
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determined by ELISA of tissue lysates. All data are means 6 SD. (*p , 0.05; **p , 0.01; ***p , 0.001, Mann-Whitney U-test).
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One of the possible reasons for the discrepancy of inflammation-
associated change of microbiota between previous studies and our
study could be the difference of the site fromwhere the samples were
obtained. Previous studies analyzed faecal or caecal samples, whereas
we analysed ileal contents. The ileum is considered to be an import-
ant organ because chylomicron is formed into small vesicles in the
epithelial cells of the ileum, and lipid is mainly absorbed from the
ileum. In addition, Peyer’s Patches are located in the ileal wall.
Therefore, as previously demonstrated with caecal bacterial53, the
bacterial composition in the ileum may have significant impact on
systemic inflammation. It is also noteworthy that in humans,
Bacteroidetes may promote type 2 diabetes through an endotoxin-
induced inflammatory response54.
Henao-Mejia et al., demonstrated that a significant expansion of
Porphyrmonadaceae was found following HFD or with methionine-
choline-deficient diet administration in the faecal microbiota in the
inflammasome-deficient setting and was associated with progression
of NAFLD and obesity55. We propose that administered P. gingivalis
is not directly responsible for the increase of the ‘‘family’’
Porphyromonadaceae in the gut, as we did not detect P. gingivalis
in the gut by using specific primers. However, bacteria belonging to
this ‘‘family’’ of bacteria may play a role in the induction of endotox-
emia and subsequent inflammatory responses. Alternatively, P. gin-
givalismay suppress inflammasome activation by other bacteria. For
example, it has been reported that P. gingivalis suppresses inflamma-
some activity through inhibition of endocytosis56.
Another interesting finding from this study was that mRNA
expression of alkaline phosphatase was downregulated in the ileum
of P. gingivalis-administered mice. Kalannen et al. previously dem-
onstrated that a defect in intestinal alkaline phosphatase (IAP), was
associated with high-fat diet-induced metabolic syndrome, and
endogenous and orally supplemented IAP inhibited endotoxin
absorption, as well as reversed metabolic syndrome in mice57.
Therefore, IAP is considered to play an important role in the
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suppression of endotoxemia. Although the underlying mechanisms
by which oral administration of P. gingivalis and/or alteration of gut
microbiota downregulate the mRNA of alkaline phosphatase has not
been clarified, downregulation of the Akp3 gene may be a factor for
elevated systemic inflammation. Moreover, gene expression analysis
of the small intestine demonstrated downregulated mRNA express-
ion of the tight junction protein ZO-1 in P. gingivalis-administered
mice. In previous studies onmouse models, the endotoxemia follow-
ing high-fat diet administrationwas associated with reduced express-
ion of genes encoding for ZO-1 and occludin34. These results suggest
that administered P. gingivalis alters the gut microbiota, and alters
the gut epithelial cell barrier function, resulting in increased gut
permeability. However, the mechanism for how this change in the
gutmicrobiota impairs gut barrier functionhas not been elucidated.P.
gingivalis administration-induced alterations of the gut microbiota
also induced upregulatedmRNA expression of various proinflamma-
tory cytokines. It is not knownwhether these inflammatory changes of
the large intestine affect systemic inflammatory responses.
In conclusion, in the present study, we demonstrated that oral
administration of P. gingivalis induced alteration of gut microbiota
as well as inflammatory changes in various tissues and organs. These
changes are considered to be attributable to increases in levels of
endotoxin in the blood. However, as with previous observations on
the influence of high-fat diet-induced metabolic endotoxemia
induced changes of the gut microbiota, it remains to be elucidated
whether a cause-and-effect relationship exists between oral admin-
istration of P. gingivalis-induced systemic inflammation and changes
in the gut microbiota. Also, further investigations are needed to
examine whether other oral bacteria have similar effects on the sys-
temic metabolism. Because the composition of the oral microflora
and gut microflora are quite distinct, the considerable flow of large
quantities of oral bacteria into gut during the frequent act of swal-
lowing could disturb the balance of the gut microflora. Furthermore,
bacterial components responsible for the alteration of gut bacterial
composition have also not been elucidated. Therefore, further studies
are needed to clarify the exact mechanisms of how P. gingivalis
induces shifts in the gut microbiota towards the production of meta-
bolic products and shifts in the composition of bacterial species
responsible for the induction of metabolic syndrome.
Methods
Mice. All experiments were performed in accordance with the Regulations and
Guidelines on Scientific and Ethical Care and Use of Laboratory Animals of the
Science Council of Japan, enforced on June 1, 2006, and approved by the Institutional
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Animal Care and Use Committee at Niigata University (permit number 39). Six-
week-old male C57BL/6N mice were obtained from Japan SLC, Inc. (Shizuoka,
Japan). The mice were acclimatized under specific pathogen-free conditions and fed
regular chow and sterile water until the commencement of infection at 8 weeks of age.
Bacterial cultures. P. gingivalis strain W83 was cultured in modified Gifu anaerobic
medium (GAM) broth (Nissui, Tokyo, Japan) in an anaerobic jar (Becton Dickinson
Microbiology System, Cockeysville, MD) in the presence of an AnaeroPackTM
(Mitsubishi Gas Chemical Co. Inc., Tokyo, Japan) for 48 hours at 37uC. Bacterial
suspensions were prepared in phosphate-buffered saline (PBS) without Mg21/Ca21
using established growth curves and spectrophotometric analysis. The number of
CFUs was standardized by measuring optical density (600 nm).
Oral administration. The murine experimental periodontitis model was developed
according to Baker et al.58 with slight modifications. A total of 109 CFU’s of live P.
gingivalis suspended in 100 ml of PBS with 2% carboxymethyl cellulose (Sigma-
Aldrich, St. Louis,MO) was given to eachmouse via a feeding needle. This suspension
was given 2 times a week for 5 weeks. The control group was sham-administered
without the P. gingivalis. During the experimental period, all mice were allowed to eat
and drink ad libitum. One day after the final treatment, oral swabs were obtained and
tested for the presence of P. gingivalis as previously described59. Mice were then
euthanized with CO2, and their tissues were removed.
Detection of P. gingivalis in blood and intestinal contents.Whole blood was taken
at at 15 min, 3, 12, and 24 hrs after a single administration of P. gingivalis. Intestinal
contents were obtained at 1, 3, and 16 hrs after administration of P. gingivalis. DNA
was extracted from whole blood and intestinal contents using a QIAampDNA Blood
Mini Kit (Qiagen, Hilden, Germany) and QIAamp DNA Stool Mini Kit (Qiagen),
respectively. Quantitative real-time PCRwas performed on a LightCyclerH 96 System
(Roche) using Fast Start Essential DNA Green Master (Roche). Universal 16S rRNA
was amplified using forward primer 59-ACTCCTACGGGAGGCAGCAGT-39 and
reverse primer 59-ATTACCGCGGCTGCTGGC-39.
P. gingivalis 16S rRNA was amplified using forward primer 59-
AGGCAGCTTGCCATACTGCG-39and reverse primer 59-
ACTGTTAGCAACTACCGATGT-39.
Gut microbiota analysis by pyrosequencing. The ileum was removed and the ileal
contents were collected using sterile water (Bio-Rad Laboratories, Hercules, CA). The
obtained ileal contents were homogenised and DNA was extracted using a
PowerSoilHDNA isolation kit (MO BIO, Carlsbad, CA). PCR was performed using a
primer set (784F:59-AGGATTAGATACCCTGGTA-39 and 1061R: 59-
CRRCACGAGCTGACGAC-39) targeting the V5-V6 region of the 16S rRNA genes60.
To amplify the targeted region, 1 ml of extracted DNA served as the template in 50-ml
reactions using KAPA HiFi HS Ready Mix (KAPA Biosystems, Woburn, MA). The
PCR protocols were 95uC for 3 min, 25 cycles of 98uC for 20 s, 60uC for 15 s, and
72uC for 15 s and 72uC for 1 min. Two 100 ml of 3-cycle reconditioning PCR
reactions were performed per sample to eliminate heteroduplexes, with 10-ml aliquots
of the initial PCR product mixture as the template and other PCR conditions
unchanged. Products of the two reconditioning PCR reactions per sample were
combined and purified using DNA clean and Concentrator-5 (ZYMO RESEARCH,
Irvine, CA). Pyrosequencing of the 16S rRNA amplicons was carried out on the 454
GS Junior platform (Roche, Basel, Switzerland). Denoising, taxonomic assignments,
and estimating relative abundance of sequencing data were performed by the analysis
pipeline of the QIIME software package61. An operational taxonomic unit (OTU) was
defined at 97% similarity. OTU indicating relative abundance of under 0.1% was
filtered to remove noise.
Glucose and insulin tolerance tests. GTTs were performed in mice orally
administered P. gingivalis and sham-administeredmice.Mice were injected i.p. with a
single dose of 1 g of glucose per kg of body weight. For the insulin tolerance test,
insulin (0.5 unit/kg) was administered by an i.p. injection. Blood samples were
collected through the tail vein before glucose or insulin injection and at 15, 30, 60, 90,
and 120 min. Blood glucose concentrations were immediately determined by the
Glucose Pilot assay (Aventir Biotech, LLC CA). The serum insulin concentration was
determined for by ELISA (Morinaga, Tokyo, Japan).
Periodontal tissue, liver and adipose tissue histology. The fixed mandibles were
dissected, decalcified, embedded, and sectioned as described previously62. Serial
sections 5 mm thick were obtained in the sagittal direction along the long axis of the
teeth and stainedwith hematoxylin and eosin.Mouse livers were embedded in Tissue-
Tek OCT (Finetechnical Sakura, Tokyo, Japan) and frozen in liquid nitrogen. Frozen
7 mm sections were obtained in a cryostat (LEICA,Wetzlar, Germany), dried at room
temperature for 60 min, fixed in 10% formaldehyde for 10 min, stainedwith oil redO
for 20 min, and counter-stained with hematoxylin.
Adipose tissue samples from sham-administered and P. gingivalis-administered
mice were fixed in 10% formalin for immunohistochemistry. Briefly, samples were
embedded in paraffin, sectioned, and stained with rat anti-mouse F4/80 antibody
(ABd Serotec, Raleigh, NC; 1550 dilution).
Cytokine assay. Proteins were extracted using T-PERMammalian Protein Extraction
Reagent (Pierce Biotechnology, Rockford, IL). C1q/TNF-related protein 9 (CTRP9)
and TNF-a were measured using the Mouse CTRP9 ELISA kit (Aviscera Bioscience,
Santa Clara, CA) and the Mouse TNFa ELISA kit (Thermo Scientific, Seattle, WA),
respectively. The total protein concentrations were measured by the Pierce BCA
Protein Assay kit (Thermo Scientific). Individual protein concentrations were
calculated as the abundance of specific protein constituents divided by the total
protein concentrations. Serum IL-6 level was determined by using a commercial
ELISA kit (Thermo Scientific).
Endotoxin assay. Endotoxin levels were determined in sera collected at 16 hrs after
final administration of P. gingivalis from the tail veins of mice using a limulus
amoebocyte lysate test (QCL-1000TM, BioWhittaker, Walkersville, MD) according
to the manufacturer’s instruction. Serum samples were diluted at 1 to 4 for the assay.
Optical densities were measured using an ELISA plate reader (Model 680, Bio-Rad
Laboratories) at 405 nm.
Liver triglyceride content. Liver triglycerides were determined with a Triglyceride
Quantification Colorimetric kit (Bio Vision, Milpitas, CA). Triglyceride values were
expressed as the concentration of triglycerides divided by the total protein
concentration. The total protein concentrations were measured by the Pierce BCA
Protein Assay kit (Thermo Scientific).
Analysis of gene expression in adipose tissue, liver, and intestine. Total RNA from
adipose tissue, liver, small intestine and large intestine samples was extracted using an
RNeasy Mini kit and treated with DNase I (Qiagen, Germantown, MD) according to
the manufacturer’s instructions. Aliquots of RNA were then reverse-transcribed to
cDNA using random primers (Takara Bio Inc., Shiga, Japan) and M-MLV reverse
transcriptase (Life Technologies Corporation, Carlsbad, CA). Primers and probes
specific for real-time PCR were purchased from Life Technologies Corporation.
Reactions were carried out in a 25-ml mixture in a LightCyclerH 96 System(Roche)
using TaqManGene Expression Assays (Life Technologies Corporation) containing a
900 nM primer and a 250 nM probe. The reactions consisted of a 10-minute
incubation at 95uC, followed by 40 cycles of a two-step amplification procedure
consisting of annealing/extension at 60uC for 1 minute and denaturation for 15
seconds at 95uC. LightCyclerH 96 software (Roche) was used to analyze the standards
and carry out the quantifications. The relative quantity of each mRNA was
normalized to the relative quantity of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA.
Statistical analysis.Nonparametric data were evaluated using theMann-Whitney U-
test for two-group comparisons, whereas comparisons of three or more groups were
analysed by one-way ANOVA with ad hoc Bonferroni post tests using Graphpad
PrismH (GraphPad Software, Inc., La Jolla, CA). A probability value of p, 0.05 was
considered statistically significant. For assessing significant differences between the P.
gingivalis-administered and sham-administered samples, we used the Mann–
Whitney U-test from the R package (http://cran.at.r-project.org/).
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